Profile
SINT ABT BSX-PA BSX SYK MDT
Company Name Sintx Technologies, Inc. Abbott Laboratories Boston Scientific Corporation Boston Scientific Corporation Stryker Corporation Medtronic plc
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Devices Medical - Devices Medical - Devices Medical - Devices Medical - Devices Medical - Devices
Market Cap $6.97M $233.14B $175.45B $152.81B $144.36B $107.25B
Employees 0.02K 114.00K 45.00K 53.00K 53.00K 95.00K
CEO Mr. Eric K. Olson Mr. Robert B. Ford Mr. Michael F. Mahoney Mr. Michael F. Mahoney Mr. Kevin A. Lobo Mr. Geoffrey Straub Martha
Ratings
SINT ABT BSX-PA BSX SYK MDT
Quant Rating Score 1 4 3 3 3
Quant Rating Strong Sell Buy Neutral Neutral Neutral
Trading
SINT ABT BSX-PA BSX SYK MDT
Last Close $2.53 $134 $122.18 $103.29 $382.46 $83.62
High 52 $9.28 $140.22 $122.18 $106.18 $399.9 $94.5
Low 52 $0.04 $100.07 $122.18 $72.81 $315.94 $76.84
Price vs. 52 Week High -72.74 % -4.44 % 0 % -2.72 % -4.36 % -11.51 %
Price vs. 52 Week Low 6225 % 33.91 % 0 % 41.86 % 21.05 % 8.82 %
Total Return
SINT ABT BSX-PA BSX SYK MDT
1 Month Return 21.05 % 5.48 % 0 % 6.74 % 5.33 % -1.95 %
3 Month Return -22.15 % 4.65 % 0 % -2.37 % -2.28 % -7.1 %
6 Month Return -12.46 % 14.93 % 0 % 17.04 % 1.73 % -4.67 %
9 Month Return -42.5 % 23.26 % 0 % 35.57 % 16.66 % 1.93 %
YTD Return -27.71 % 18.47 % 0 % 15.64 % 6.22 % 4.68 %
1 Year Return 5689.47 % 28.02 % 0 % 39.39 % 15.6 % 1.04 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
SINT ABT BSX-PA BSX SYK MDT
Dividend Yield Percentage (TTM) - 1.7 % - - 0.87 % 3.35 %
Dividend Paid and Capex Coverage Ration (TTM) -12.52 % 1.57 % 3.96 % 3.96 % 2.2 % 1.34 %
Dividend Per Share (TTM) - 2.28 % - - 3.28 % 2.8 %
Payout Ratio (TTM) - 28.92 % 1.13 % 1.13 % 43.2 % 84.62 %
Growth
SINT ABT BSX-PA BSX SYK MDT
Asset Growth -38.74 % 11.2 % 12.12 % 12.12 % -1.06 %
Gross Profit Growth 12.64 % 5.01 % 16.12 % 16.12 % 3.12 %
Revenue Growth 9.9 % 4.59 % 17.61 % 17.61 % 3.64 %
Revenue 3 Year 32.65 % -0.18 % 36.16 % 36.16 % 8.85 %
Revenue 5 Year -91.2 % 34.24 % 47.52 % 47.52 % 7.41 %
Revenue 10 Year -100 % 80.43 % 104.22 % 104.22 % 43.65 %
EBIT Growth -33.86 % 3.71 % 14.98 % 14.98 % -7.4 %
Net Income Growth -33.48 % 134.18 % 16.32 % 16.32 % -2.18 %
Net Income 3 Yeari Growth Per Share 68.75 % 94.27 % 72.05 % 72.05 % 3.26 %
Net Income 5 Yeari Growth Per Share 95.23 % 271.11 % -62.72 % -62.72 % -19.5 %
Net Income 10 Yeari Growth Per Share 100 % 410.99 % 524.58 % 524.58 % -9.48 %
Operating Income Growth -5.16 % 5.36 % 11.1 % 11.1 % -6.22 %
Operating Cash Flow Growth (CFG) 38.77 % 17.86 % 37.24 % 37.24 % 12.39 %
Operating 3 Year CFG 76.25 % -16.72 % 77.55 % 77.55 % 10.18 %
Operating 5 Year CFG 97.18 % 42.4 % 76.92 % 76.92 % -1.78 %
Operating 10 Year CFG 100 % 102.79 % 143.61 % 143.61 % 3.3 %
EPS Growth 95.79 % 134.55 % 16.67 % 16.67 % -2.12 %
EPS Diluted Growth -762085.74 % 133.64 % 16.82 % 16.82 % -2.13 %
Book Value Per Share -77 % 23.54 % 11.25 % 11.25 % -2.26 %
Share Holder 3 Year Equity Growth Per Share -93.88 % 36.46 % 26.58 % 26.58 % -1.1 %
Share Holder 5 Year Equity Growth Per Share -98.43 % 56.53 % 48.35 % 48.35 % 1.66 %
Share Holder 10 Year Equity Growth Per Share -100 % 92.83 % 186.31 % 186.31 % 94.93 %
Dividend Per Share Growth - 8.02 % -100 % -100 % 1.54 %
Dividend 3 Year Growth Per Share - 22.8 % -100 % -100 % 19.02 %
Dividend 5 Year Growth Per Share - 72.53 % - - 38.05 %
Dividend 10 Year Growth Per Share - 148.92 % - - 147.94 %
Debt Growth -5.18 % -5.37 % 13.21 % 13.21 % 6.91 %
Free Cash Flow Growth 36.28 % 25.54 % 55.31 % 55.31 % 13.54 %
Updated On 31 Dec 2024 31 Dec 2024 31 Dec 2024 31 Dec 2024 26 Apr 2024
Profitability
SINT ABT BSX-PA BSX SYK MDT
Gross Profit Margin TTM 51.48 % 55.89 % 67.15 % 67.15 % 63.57 % 62.89 %
Return on Assets TTM -117.11 % 16.58 % 5.06 % 5.06 % 6.21 % 4.73 %
Return on Equity TTM -156.11 % 24.5 % 9.56 % 9.56 % 10.73 % 8.69 %
Return on Capital Employed TTM -189.03 % 10.5 % 8.77 % 8.77 % 9.61 % 7.74 %
Net Income Per EBT TTM 100 % 183.58 % 81.97 % 81.97 % 85.78 % 81.56 %
EBT Per Ebit TTM 78.48 % 102.35 % 80.59 % 80.59 % 91.04 % 86.39 %
EBIT Per Revenue TTM -553.69 % 16.97 % 17.52 % 17.52 % 15.77 % 18.21 %
Cash Flow To Debt Ratio TTM -214.71 % 67.59 % 32.56 % 32.56 % 29.81 % 27.41 %
Receivables Turnover TTM 12.94 - 6.52 6.52 5.86 5.43
Payables Turnover TTM 4.12 4.43 5.74 5.74 - 5.39
Inventory Turnover TTM 2.45 2.81 2.01 2.01 1.66 2.2
Fixed Asset Turnover TTM 62.17 % 387.34 % 517.94 % 517.94 % 656.62 % 503.55 %
Asset Turnover TTM 26.95 % 51.99 % 43.73 % 43.73 % 50.47 % 36.9 %
Operating Cash Flow Per Share TTM -6.44 5.12 2.58 2.58 11.23 5.69
Free Cash Flow Per Share TTM -6.95 3.81 1.94 1.94 9.37 4.26
Cash Per Share TTM 267.94 % 391.71 % 49.08 % 49.08 % 631.12 % 617.75 %
Operating Cash Flow Sales Ratio TTM -340.64 % 21.14 % 21.72 % 21.72 % 18.47 % 21.97 %
Free Cash Flow Operating Cash Flow Ratio TTM 107.98 % 74.38 % 75.37 % 75.37 % 83.42 % 74.96 %
Cash Flow Coverage Ratios TTM -214.71 % 67.59 % 32.56 % 32.56 % 29.81 % 27.41 %
Price To Free Cash Flows Ratio TTM -0.75 35.02 53.6 53.19 40.36 19.62
Price To Operating Cash Flows Ratio TTM -0.43 26.16 40.35 40.03 33.67 14.7
Price Cash Flow Ratio TTM -0.43 26.16 40.35 40.03 33.67 14.7
Income Statement (TTM)
SINT ABT BSX-PA BSX SYK MDT
Revenue $0B $41.95B $16.75B $16.75B $22.6B $32.36B
Gross Profit $0B $23.24B $11.49B $11.49B $14.44B $21.15B
Gross Profit Ratio 71.91% 55.41% 68.61% 68.61% 63.91% 65.34%
EBITDA $-0.01B $10.83B $3.94B $3.94B $5.72B $8.2B
Net Income $-0.01B $13.4B $1.85B $1.85B $2.99B $3.68B
EPS Diluted -148016.47 7.64 1.25 1.25 7.76 2.76
Balance Sheet (MRQ)
SINT ABT BSX-PA BSX SYK MDT
Long Term Debt $0B $13.52B $8.84B $8.84B $12.19B $24.77B
Total Liabilities $0.01B $33.51B $17.39B $17.39B $22.34B $39.56B
Total Equity $0B $47.9B $22B $22B $20.63B $50.42B
Total Investments $0B $1.24B $0.56B $0.56B $0.84B $8.34B
Total Debt $0B $15.02B $11.15B $11.15B $13.6B $26.05B
Total Assets $0.01B $81.41B $39.4B $39.4B $42.97B $89.98B
Cash Flow Statement (TTM)
SINT ABT BSX-PA BSX SYK MDT
Net Income $-0.01B $13.4B $1.85B $1.85B $2.99B $3.68B
Inventory $0B $-0.06B $-0.23B $-0.23B $0.05B $-0.14B
Dividends Paid $0B $-3.84B $0B $0B $-1.22B $-3.67B
Operating Cash Flow $-0.01B $8.56B $3.44B $3.44B $4.24B $6.79B
Capital Expenditure $-0B $-2.21B $-0.79B $-0.79B $-0.76B $-1.59B
Related Stocks
Ticker Name Price
ABMD Abiomed, Inc. 381.02
ABT Abbott Laboratories 134
ADGM Adagio Medical Holdings, Inc. 1.39
AEMD Aethlon Medical, Inc. 0.3689
AFIB Acutus Medical, Inc. 0.04
AHCO AdaptHealth Corp. 8.375
AHPI Allied Healthcare Products, Inc. 0.004
ALGN Align Technology, Inc. 180.93
ALUR Allurion Technologies Inc. 2.36
AMIX Autonomix Medical, Inc. Common Stock 1.7
ANIK Anika Therapeutics, Inc. 14.74
AORT Artivion, Inc. 28.53
APEN Apollo Endosurgery, Inc. 10
APYX Apyx Medical Corporation 1.18
ASXC Asensus Surgical, Inc. 0.3479
ATEC Alphatec Holdings, Inc. 12.74
AVNS Avanos Medical, Inc. 12.58
AVR Anteris Technologies Global Corp. Common Stock 4.38
AXDX Accelerate Diagnostics, Inc. 0.138
AXGN AxoGen, Inc. 12.59
ETFs With Exposure to SINT
Ticker ETF Name Weight Percentage Price
ITOT iShares Core S&P Total U.S. Stock Market ETF 0 123.5
VXF Vanguard Extended Market Index Fund 0 177.37
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0 134.56
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0 134.57
VEMPX Vanguard Extended Market Index InstlPlus 0 332.06
Unlock